The Temple City, California-based NGS genetic testing firm more than doubled its number of billable tests compared to the prior-year period.
The consortium is comprised of researchers from Inova, Roswell Park Comprehensive Cancer Center, the Mayo Clinic, and MD Anderson Cancer Center.
The findings suggest a potential avenue to treat or prevent Alzheimer's disease, the researchers said.
An analysis of placental, parental, and cord blood samples indicated that an uptick in chromosomal instability in cleavage-stage in vitro fertilization embryos does not persist after birth.
Among the study's goals is to identify molecular signatures that can distinguish idiopathic pulmonary fibrosis from interstitial lung disease.
The five-year funding commitment represents a 5 percent increase over the previous grant period for the rapidly growing archive of 3D protein structures.
The company said it will use the net proceeds for general corporate purposes and to fund ongoing operations and expansion of its business.
Last week, GenomeWeb's readers were most interested in new products from Chinese sequencing instrument maker MGI Tech, including a portable sequencing system.
MGI Tech will market Pillar Biosciences' Onco/Reveal NGS panels alongside its high-throughput, automated library prep systems outside the US.
The approval allows the company to directly market and sell the CTC technology to labs and other institutions to develop and implement IVD tests.
The GenomeWeb index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index.
The two companies have been working together since February and now are formalizing plans to develop and test new products.
Analyzing patient exome sequence data, investigators identified germline variants with apparent ties to estrogen receptor-positive breast cancer recurrence.
News items for the week of Oct. 28, 2019
Recent local coverage determinations from Medicare Administrative Contractors, posted Nov. 1, 2019.
The researchers combined genomic, transcriptomic, and proteomic profiling to gain insight into the basic biology and possible treatments for the disease.
B-cell receptor sequencing revealed lower-than-usual memory immune cell activity and more in unvaccinated children after measles virus infection.
The firm saw modest growth across both of its business segments and double-digit growth in its droplet digital PCR product line.
Revenues rose to $521.1 million from $466.6 million in Q3 2018, beating the consensus Wall Street estimate of $496.7 million.
The company reported $33.8 million in total revenues for the quarter and said testing services revenues rose 68 percent year over year.
The Unity test enables screening for several autosomal recessive conditions from fetal DNA gathered from maternal blood.
By combining conventional karyotyping and low-pass sequencing, researchers found chromosomal abnormalities in 1 in 8 couples with recurrent miscarriage.
Researchers documented population structure, ancestry patterns, trait associations, and more with variants found in the genomes of more than 6,400 Ugandans.
The General Data Protection Regulation has slowed some data sharing with non-European researchers as they find ways to comply with the law, ScienceInsider reports.
A bioethicist from Abertay University uses a utilitarian approach to justify genetically modifying the human germline, the BBC reports.
The US has upgraded its network of public health labs to provide whole-genome sequencing to track antibiotic-resistant bacteria, Quartz reports.
In Science this week: approach to visualize 3D genome structure in single cells, RNA interference knockdown screens to examine genetic origins of beetle horns and insect wings, and more.